Korea's Celltrion Banks On Increasing Profits Resulting From New Focus On Biosimilars

SEOUL - Biopharmaceutical firm Celltrion posted a record performance in the most recent quarter due to the company's shift in focus from contract manufacturing to producing biosimilars